Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice

Katrina L. Watson(University of Guelph), Roger A. Moorehead(University of Guelph)

BMC Cancer

August 7, 2013

10.1186/1471-2407-13-375

Cited by 17

Related Papers

Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland

|Journal of Biological Chemistry|2003|69

Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells

|BMC Cancer|2016|34

BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549

|BMC Research Notes|2016|30

Unique roles of<i>Akt1</i>and<i>Akt2</i>in IGF-IR mediated lung tumorigenesis

|Oncotarget|2015|29

Re-expression of miR-200c suppresses proliferation, colony formation and<i>in vivo</i>tumor growth of murine claudin-low mammary tumor cells

|Oncotarget|2017|25